It’s no secret that the United States has documented disparities in morbidity and mortality rates among racial/ethnic minority groups and those of lower socioeconomic status. More recently we’ve seen a disproportionate amount of African Americans affected by COVID-19, but they have been underrepresented in clinical research. In this podcast we are joined by Kimberly Richardson, Patient Advocate and Cancer Survivor, to discuss how we can work towards achieving health equity in the United States, what steps can be taken today, and the impact this would have on clinical research and underserved communities.
With the rise of decentralized trials comes a focus on patient-centricity, but what does that look like holistically? Trishna Bharadia joins us to discuss...
Constantly changing regulations and a multitude of new endpoints continue to keep clinical researchers on their toes. While these regulations and endpoints are designed...
Welcome to the Trial Talks podcast, a thought-provoking show about clinical research. On this podcast, we will be exploring trends in the industry as...